Intestinal microflora and digestive toxicity of irinotecan in mice

被引:83
作者
Brandi, G
Dabard, J
Raibaud, P
Di Battista, M
Bridonneau, C
Pisi, AM
Labate, AMM
Pantaleo, MA
De Vivo, A
Biasco, G
机构
[1] Sant Orsola Malpighi Hosp, LA Seragnoli Inst Haematol & Med Oncol, Bologna, Italy
[2] Sant Orsola Malpighi Hosp, Dept Internal Med & Gastroenterol, Bologna, Italy
[3] Univ Bologna, Dept Sci & Agroenvironm Technol, Bologna, Italy
[4] INRA, Unite Ecol & Physiol Syst Digestif, Jouy En Josas, France
关键词
D O I
10.1158/1078-0432.CCR-05-0750
中图分类号
R73 [肿瘤学];
学科分类号
100214 [肿瘤学];
摘要
Purpose: Delayed diarrhea is the most important side effect of irinotecan. The aim of this study was to investigate the role of intestinal microflora on the induction of systemic and intestinal toxicity and diarrhea, studying germ-free and holoxenic mice i.p. injected with irinotecan. Experimental Design: To evaluate the lethal dose, starting with 100 mg/kg/4 d, we treated the holoxenic mice with 100, 80, and 60 mg/kg/4 d and germ-free mice with 60, 80,100, and 150 mg/ kg/4 d. We recorded the percentage of dead animals, diarrhea, and the epithelial damage to the jejunum, ileum, cecum, and colon at optical and scanning electron microscopy. Results: Germ-free mice were more resistant to irinotecan than the holoxenic group. The lethal dose was between 60 and 80 mg of irinotecan for holoxenic mice and >= 150 mg for the germ-free. The intestinal damage score was higher in holoxenic than germ-free mice at 100 mg and equally diffuse in the small and large bowel. The damage in germ-free mice was less severe (8 of 40 samples) prevailing in the ileum. The differences were significant for all sites (jejunum, P < 0.001; ileum, P = 0.012; cecum, P = 0.001; colon, P < 0.001). No damage was found in germ-free mice at 60 mg. Diarrhea was present in all 100 and 80 mg holoxenic mice and in 19 of 20 cases at 60 mg whereas it was absent in 60 mg or sporadic in 80 and 100 mg germ-free mice. Conclusions: The intestinal microflora plays a key role in the intestinal toxicity of irinotecan.
引用
收藏
页码:1299 / 1307
页数:9
相关论文
共 44 条
[1]
Prevention of irinotecan plus 5-fluorouracil/leucovorin-induced diarrhoea by oral administration of neomycin plus bacitracin in first-line treatment of advanced colorectal cancer [J].
Alimonti, A ;
Satta, F ;
Pavese, I ;
Burattini, E ;
Zoffoli, V ;
Vecchione, A .
ANNALS OF ONCOLOGY, 2003, 14 (05) :805-806
[2]
RELATIONSHIP BETWEEN DEVELOPMENT OF DIARRHEA AND THE CONCENTRATION OF SN-38, AN ACTIVE METABOLITE OF CPT-11, IN THE INTESTINE AND THE BLOOD-PLASMA OF ATHYMIC MICE FOLLOWING INTRAPERITONEAL ADMINISTRATION OF CPT-11 [J].
ARAKI, E ;
ISHIKAWA, M ;
IIGO, M ;
KOIDE, T ;
ITABASHI, M ;
HOSHI, A .
JAPANESE JOURNAL OF CANCER RESEARCH, 1993, 84 (06) :697-702
[3]
BRANDI G, 1998, ULTRASTRUCTURE ECOLO, P68
[4]
Randomised trial of irinotecan plus supportive care versus supportive care alone after fluorouracil failure for patients with metastatic colorectal cancer [J].
Cunningham, D ;
Pyrhönen, S ;
James, RD ;
Punt, CJA ;
Hickish, TF ;
Heikkila, R ;
Johannesen, TB ;
Starkhammar, H ;
Topham, CA ;
Awad, L ;
Jacques, C ;
Herait, P .
LANCET, 1998, 352 (9138) :1413-1418
[5]
Drasar B.S., 1988, The Role of the Gur Flora in Toxicity and Cancer, P23
[6]
Erlichman C, 2001, NEW ENGL J MED, V344, P305
[7]
BETA-GLUCURONIDASE ACTIVITIES OF INTESTINAL BACTERIA DETERMINED BOTH INVITRO AND INVIVO IN GNOTOBIOTIC-RATS [J].
GADELLE, D ;
RAIBAUD, P ;
SACQUET, E .
APPLIED AND ENVIRONMENTAL MICROBIOLOGY, 1985, 49 (03) :682-685
[8]
A NEW ENKEPHALINASE INHIBITOR AS AN ALTERNATIVE TO LOPERAMIDE IN THE PREVENTION OF DIARRHEA INDUCED BY CPT-11 [J].
GONCALVES, E ;
DACOSTA, L ;
ABIGERGES, D ;
ARMAND, JP .
JOURNAL OF CLINICAL ONCOLOGY, 1995, 13 (08) :2144-2146
[9]
Effect of thalidomide on gastrointestinal toxic effects of irinotecan [J].
Govindarajan, R ;
Heaton, KM ;
Broadwater, R ;
Zeitlin, A ;
Lang, NP ;
Hauer-Jensen, M .
LANCET, 2000, 356 (9229) :566-567
[10]
Commensal host-bacterial relationships in the gut [J].
Hooper, LV ;
Gordon, JI .
SCIENCE, 2001, 292 (5519) :1115-1118